top of page
    • Aug 13

Financing Round

Scope Law advises Crearene AG, Frauenfeld, Switzerland on further equity financing.

Crearene, an innovative medical technology company focused on improving the quality of life of dialysis patients by supplementing dialysis fluid with creatine, has successfully completed a further financing round with existing investors.


Recent Posts

See All

M&A Transaction

Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A.  (Greece) on its sale to Rosemont Pharmaceuticals Ltd....

M&A Transaction

Scope Law advised Expat Payroll AG, Zurich on the acquisition of a business division from KRESTON ZURICH AG, Zurich by way of a transfer...

Seed Financing Round

Scope Law advised the healthtech startup Adamcares AG in a further tranche of the successfully completed seed financing round with Swiss...

コメント

bottom of page